Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mjardin’s Nova Scotia Cannabis Facility Hits Full Capacity

Stockhouse Editorial
1 Comment| April 18, 2019

{{labelSign}}  Favorites
{{errorMessage}}

Cannabis management platform Mjardin Group Inc. (CSE:MJAR, OTC:MJARF, Forum) reported on Thursday that its joint-venture AtlantiCann Medical Inc. facility located in Lower Sackville, Nova Scotia has now reached its full production capacity of 4,700 kg of flower and trim. AMI is a three-way JV consisting of Nova Scotia Mi’kmaq First Nations (51 per-cent), MJardin Group, Inc. (39 per-cent) and the Halef Group (10 per-cent). Phase 1 of the AMI complex is a 48,000 square foot cultivation and extraction facility.

For more on this JV and facility, click here.

Boasting extensive experience in cultivation, processing, distribution and retail, the Company recently its Ontario facility exceeds historical Company yields.


FULL DISCLOSURE: Mjardin Group Inc. is a client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company